QQQ   304.37 (-1.78%)
AAPL   151.92 (-1.77%)
MSFT   266.73 (-0.31%)
META   183.43 (-4.27%)
GOOGL   99.37 (-7.68%)
AMZN   100.05 (-2.02%)
TSLA   201.29 (+2.28%)
NVDA   222.05 (+0.14%)
NIO   10.65 (-2.47%)
BABA   105.11 (-0.37%)
AMD   84.69 (-1.42%)
T   19.16 (-0.47%)
F   13.42 (-0.22%)
MU   60.25 (-3.03%)
CGC   2.74 (-2.84%)
GE   81.96 (-0.18%)
DIS   111.78 (+0.13%)
AMC   5.72 (-7.44%)
PFE   43.98 (+0.89%)
PYPL   79.72 (-4.22%)
NFLX   366.83 (+1.07%)
QQQ   304.37 (-1.78%)
AAPL   151.92 (-1.77%)
MSFT   266.73 (-0.31%)
META   183.43 (-4.27%)
GOOGL   99.37 (-7.68%)
AMZN   100.05 (-2.02%)
TSLA   201.29 (+2.28%)
NVDA   222.05 (+0.14%)
NIO   10.65 (-2.47%)
BABA   105.11 (-0.37%)
AMD   84.69 (-1.42%)
T   19.16 (-0.47%)
F   13.42 (-0.22%)
MU   60.25 (-3.03%)
CGC   2.74 (-2.84%)
GE   81.96 (-0.18%)
DIS   111.78 (+0.13%)
AMC   5.72 (-7.44%)
PFE   43.98 (+0.89%)
PYPL   79.72 (-4.22%)
NFLX   366.83 (+1.07%)
QQQ   304.37 (-1.78%)
AAPL   151.92 (-1.77%)
MSFT   266.73 (-0.31%)
META   183.43 (-4.27%)
GOOGL   99.37 (-7.68%)
AMZN   100.05 (-2.02%)
TSLA   201.29 (+2.28%)
NVDA   222.05 (+0.14%)
NIO   10.65 (-2.47%)
BABA   105.11 (-0.37%)
AMD   84.69 (-1.42%)
T   19.16 (-0.47%)
F   13.42 (-0.22%)
MU   60.25 (-3.03%)
CGC   2.74 (-2.84%)
GE   81.96 (-0.18%)
DIS   111.78 (+0.13%)
AMC   5.72 (-7.44%)
PFE   43.98 (+0.89%)
PYPL   79.72 (-4.22%)
NFLX   366.83 (+1.07%)
QQQ   304.37 (-1.78%)
AAPL   151.92 (-1.77%)
MSFT   266.73 (-0.31%)
META   183.43 (-4.27%)
GOOGL   99.37 (-7.68%)
AMZN   100.05 (-2.02%)
TSLA   201.29 (+2.28%)
NVDA   222.05 (+0.14%)
NIO   10.65 (-2.47%)
BABA   105.11 (-0.37%)
AMD   84.69 (-1.42%)
T   19.16 (-0.47%)
F   13.42 (-0.22%)
MU   60.25 (-3.03%)
CGC   2.74 (-2.84%)
GE   81.96 (-0.18%)
DIS   111.78 (+0.13%)
AMC   5.72 (-7.44%)
PFE   43.98 (+0.89%)
PYPL   79.72 (-4.22%)
NFLX   366.83 (+1.07%)
NASDAQ:ADMP

Adamis Pharmaceuticals - ADMP Stock Forecast, Price & News

$0.22
+0.01 (+4.76%)
(As of 02/8/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.21
▼
$0.23
50-Day Range
$0.14
▼
$0.23
52-Week Range
$0.12
▼
$0.73
Volume
359,124 shs
Average Volume
518,252 shs
Market Capitalization
$33.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ADMP stock logo

About Adamis Pharmaceuticals (NASDAQ:ADMP) Stock

Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development, and sale of pharmaceutical, specialty biopharmaceutical, and other drug products. The company provides products in various therapeutic areas, including allergy, respiratory, opioid overdose, and erectile dysfunction markets. It offers the SYMJEPI Injection for the emergency treatment of allergic reactions. The company was founded in June 2006 and is headquartered in San Diego, CA.

Receive ADMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adamis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ADMP Stock News Headlines

February 7, 2023 | americanbankingnews.com
Adamis Pharmaceuticals (NASDAQ:ADMP) Now Covered by Analysts at StockNews.com
January 31, 2023 | americanbankingnews.com
StockNews.com Initiates Coverage on Adamis Pharmaceuticals (NASDAQ:ADMP)
February 8, 2023 | Legacy Research (Affiliate) (Ad)
The One Ticker Retirement Plan Over the Shoulder Demo Now Available
Market Wizard Larry Benedict crushed the market in 2022. But he hasn’t done it with a “traditional” method… For a limited time, he’s sharing a free over-the-shoulder “demo” of his strategy in action. It takes less than 10 seconds…
January 30, 2023 | americanbankingnews.com
Adamis Pharmaceuticals Co. (NASDAQ:ADMP) Short Interest Update
December 29, 2022 | finance.yahoo.com
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Q3 2022 Earnings Call Transcript
November 15, 2022 | finanznachrichten.de
Adamis Pharmaceuticals Corporation: Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 15, 2022 | seekingalpha.com
Adamis Pharmaceuticals Corporation (ADMP) Q3 2022 Earnings Call Transcript
November 15, 2022 | finance.yahoo.com
Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
February 8, 2023 | Legacy Research (Affiliate) (Ad)
The One Ticker Retirement Plan Over the Shoulder Demo Now Available
Market Wizard Larry Benedict crushed the market in 2022. But he hasn’t done it with a “traditional” method… For a limited time, he’s sharing a free over-the-shoulder “demo” of his strategy in action. It takes less than 10 seconds…
November 12, 2022 | msn.com
A Preview Of Adamis Pharmaceuticals's Earnings
November 7, 2022 | finance.yahoo.com
Adamis Pharmaceuticals Schedules Third Quarter 2022 Financial Results Conference Call and Corporate Update
October 18, 2022 | msn.com
Why fuboTV Shares Are Trading Higher By 11%; Here Are 22 Stocks Moving Premarket
October 12, 2022 | msn.com
Why Cango Shares Are Trading Higher; Here Are 27 Stocks Moving Premarket
October 5, 2022 | marketwatch.com
Adamis Pharmaceuticals Shares Jump 14% On Potential Sale, Strategic Alternatives
October 3, 2022 | nasdaq.com
Adamis Pharma To Explore Strategic Alternatives; Stock Up 10%
October 3, 2022 | finance.yahoo.com
Adamis Announces Review of Strategic Alternatives
September 30, 2022 | seekingalpha.com
Adamis Pharmaceuticals: Managing A Position In A Company Diagnosed With Chronic Failure
September 23, 2022 | seekingalpha.com
ADMP Adamis Pharmaceuticals Corporation
September 21, 2022 | seekingalpha.com
Adamis says Phase 2/3 trial for COVID-19 therapy did not reach main goal
September 21, 2022 | marketwatch.com
Adamis Pharmaceuticals Sink to New Lows After Study Failure >ADMP
September 21, 2022 | finance.yahoo.com
Adamis Pharma Shares Nosedive As Its COVID-19 Candidate Shows No Efficacy
September 21, 2022 | marketwatch.com
Adamis Ends Tempol Covid-19 Study After Main Endpoint Missed >ADMP
September 21, 2022 | finance.yahoo.com
Adamis Provides Update on the Phase 2/3 Trial of Tempol in COVID-19 Positive High-Risk Subjects
September 12, 2022 | finance.yahoo.com
Adamis Provides an Enrollment Update on the Phase 2/3 Study of Tempol in COVID-19 Positive High-Risk Subjects
August 30, 2022 | thestreet.com
Adamis Pharmaceuticals Corporation
August 12, 2022 | finance.yahoo.com
Adamis Pharmaceuticals Announces Results of Annual Meeting of Stockholders
August 11, 2022 | seekingalpha.com
Adamis Pharmaceuticals Corporation (ADMP) CEO David J. Marguglio on Q2 2022 Results - Earnings Call Transcript
See More Headlines
Receive ADMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adamis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ADMP Company Calendar

Last Earnings
11/14/2022
Today
2/08/2023
Next Earnings (Estimated)
3/30/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ADMP
CUSIP
N/A
CIK
887247
Web
www.adamispharmaceuticals.com
Phone
(858) 997-2400
Fax
N/A
Employees
116
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-45,830,000.00
Net Margins
N/A
Pretax Margin
-2,069.43%
Return on Equity
-237.90%
Return on Assets
-124.57%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.14
Quick Ratio
1.01

Sales & Book Value

Annual Sales
$2.21 million
Price / Sales
14.93
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.17 per share
Price / Book
1.29

Miscellaneous

Outstanding Shares
149,980,000
Free Float
141,134,000
Market Cap
$33.00 million
Optionable
Optionable
Beta
1.32

Key Executives

  • David J. Marguglio
    President, Chief Executive Officer & Director
  • David C. Benedicto
    Chief Financial & Accounting Officer
  • Thomas H. Moll
    Vice President-Research

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













ADMP Stock - Frequently Asked Questions

How have ADMP shares performed in 2023?

Adamis Pharmaceuticals' stock was trading at $0.1693 at the start of the year. Since then, ADMP stock has increased by 32.8% and is now trading at $0.2249.
View the best growth stocks for 2023 here.

Are investors shorting Adamis Pharmaceuticals?

Adamis Pharmaceuticals saw a decline in short interest during the month of January. As of January 15th, there was short interest totaling 1,910,000 shares, a decline of 23.9% from the December 31st total of 2,510,000 shares. Based on an average daily trading volume, of 754,700 shares, the days-to-cover ratio is presently 2.5 days.
View Adamis Pharmaceuticals' Short Interest.

When is Adamis Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 30th 2023.
View our ADMP earnings forecast.

How were Adamis Pharmaceuticals' earnings last quarter?

Adamis Pharmaceuticals Co. (NASDAQ:ADMP) released its earnings results on Monday, November, 14th. The specialty pharmaceutical company reported ($0.03) earnings per share (EPS) for the quarter. The specialty pharmaceutical company had revenue of $1.51 million for the quarter.

What other stocks do shareholders of Adamis Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Adamis Pharmaceuticals investors own include Trevena (TRVN), Amarin (AMRN), Sorrento Therapeutics (SRNE), Verastem (VSTM), Dynavax Technologies (DVAX), Novavax (NVAX), SCYNEXIS (SCYX), Synergy Pharmaceuticals (SGYP), Agile Therapeutics (AGRX) and OPKO Health (OPK).

What is Adamis Pharmaceuticals' stock symbol?

Adamis Pharmaceuticals trades on the NASDAQ under the ticker symbol "ADMP."

Who are Adamis Pharmaceuticals' major shareholders?

Adamis Pharmaceuticals' stock is owned by many different retail and institutional investors. Top institutional investors include Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include David C Benedicto, David J Marguglio, Dennis J Phd Carlo, Karen K Daniels, Robert O Hopkins and Ronald B Moss.
View institutional ownership trends.

How do I buy shares of Adamis Pharmaceuticals?

Shares of ADMP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Adamis Pharmaceuticals' stock price today?

One share of ADMP stock can currently be purchased for approximately $0.22.

How much money does Adamis Pharmaceuticals make?

Adamis Pharmaceuticals (NASDAQ:ADMP) has a market capitalization of $33.73 million and generates $2.21 million in revenue each year.

How many employees does Adamis Pharmaceuticals have?

The company employs 116 workers across the globe.

How can I contact Adamis Pharmaceuticals?

Adamis Pharmaceuticals' mailing address is 11682 EL CAMINO REAL SUITE 300, SAN DIEGO CA, 92130. The official website for the company is www.adamispharmaceuticals.com. The specialty pharmaceutical company can be reached via phone at (858) 997-2400 or via email at mflather@adamispharma.com.

This page (NASDAQ:ADMP) was last updated on 2/8/2023 by MarketBeat.com Staff